Evidence map›Paper›PMID 39188348›Full record

ArticleSmart medicine2023

Dimensional effect of graphene nanostructures on cytoskeleton-coupled anti-tumor metastasis.

Qiqige Du, Na Li, Jiaqi Lian, Jun Guo, Yi Zhang, Feng Zhang

Abstract read
In one paragraph

Article in Smart medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiqige DuWenzhou Institute University of Chinese Academy of Sciences Wenzhou China.ORCID https://orcid.org/0009-0004-6303-1936
Na LiKey Laboratory of Optical Technology and Instrument for Medicine Ministry of Education University of Shanghai for Science and Technology Shanghai China.
Jiaqi LianKey Laboratory of Optical Technology and Instrument for Medicine Ministry of Education University of Shanghai for Science and Technology Shanghai China.
Jun GuoWenzhou Institute University of Chinese Academy of Sciences Wenzhou China.
Yi ZhangShanghai Advanced Research Institute Chinese Academy of Sciences Shanghai China.
Feng ZhangWenzhou Institute University of Chinese Academy of Sciences Wenzhou China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interactions between inorganic materials and living systems can be strongly influenced by the dimensional property of the materials, which can in turn impact biological activities. Although the role of biomaterials at the molecular and cellular scales has been studied, research investigating the effects of biomaterials across multiple dimensional scales is relatively scarce. Herein, comparing the effectiveness of two-dimensional graphene oxide nanosheets (GOs) and three-dimensional graphene oxide quantum dots (GOQDs) (though not zero-dimensional because of their significant surface area) in cancer therapies, we have discovered that GOs, with the same mass concentration, exhibit stronger anti-cancer and anti-tumor metastasis properties than GOQDs. Our research, which employed liquid-phase atomic force microscopy, revealed that lower-dimensional GOs create a more extensive nano-bio interface that impedes actin protein polymerization into the cytoskeleton, leading to the prevention of tumor metastasis. These results help to better understand the underlying mechanisms and offer a dimensional perspective on the potential of optimizing the properties of graphene-based materials for clinical applications, e.g., cancer therapy.

Indexed as

actin cytoskeletoncancer cell migrationdimensional effectsgraphene‐based nanomaterialsreal‐time polymerization

Identifiers

PMID39188348
PMCPMC11235939

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.